Analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of KalVista Pharmaceuticals in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sagimet Biosciences, Inc. Class A (SGMT – ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
A series of injectable and oral treatments that require chronic dosing are already available, while others are nearing the market, including KalVista Pharma's recently filed oral plasma kallikrein ...
After hours: January 24 at 4:01:53 PM EST Loading Chart for KALV ...
After hours: January 24 at 4:01:53 p.m. EST ...
After hours: January 24 at 4:00:09 PM EST Loading Chart for ABEO ...
21 RFL Rafael Holdings, Inc. Class B 0.00% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback